Patent · US Active

Medical use of CREG protein

US11020450B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

GENERAL HOSPITAL OF CHINESE PLA NORTHERN THEATER COMMAND · CN

Inventors

Yaling Han · Shenyang, CN
Chenghui YAN · Shenyang, CN
Dan Liu · Beijing, CN
Xiaoxiang TIAN · Shenyang, CN
Yang Li · Shanghai, CN
Xiaolin Zhang · Singapore, SG
Haixu Song · Shenyang, CN
Meili Liu · Beijing, CN

Key dates

Filing date	Apr 19, 2016
Grant date	Jun 1, 2021
Priority date	—
Expiry date	Oct 20, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/325
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a medical use of Cellular Repressor of E1A-stimulated Genes (CREG), in particular to a use of CREG protein or active fragment thereof in manufacture of a medicament for preventing and/or treating myocardial infarction, a use in manufacture of a medicament for preventing and/or treating ventricular remodeling after myocardial infarction and heart failure after myocardial infarction, a use in manufacture of a medicament for prevention and/or treatment of myocardial ischemia-reperfusion injury, a use in manufacture of a medicament for prevention and/or treatment of salt-sensitive hypertensive myocardial fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.